Nirsevimab is protective against RSV infections and coinfections, which suggests there is no replacement of RSV with other viruses post-nirsevimab administration.
North Carolina State University researchers continue to push the field of plant disease diagnosis forward, developing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback